Pre-hospital Thrombolytic Intervention in the Treatment of Acute Myocardial Infarction
In an attempt to limit infarct size, the objective of treatment of acute myocardial infarction (AMI) has changed in the past 20 years from limitation of myocardial oxygen consumption (nitrates, beta-blockers, vasodilators) towards improvement of tissue oxygen availability by dissolving the occluding thrombus in the infarctrelated coronary artery. Well-designed controlled studies have proven the value of thrombolytic treatment, especially when initiation occurs very early [1–6].
KeywordsAcute Myocardial Infarction Acute Myocardial Infarction Thrombolytic Treatment Anisoylated Plasminogen Streptokinase Activator Complex Thrombolytic Drug
Unable to display preview. Download preview PDF.
- 5.GISSI (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet i:397–402.Google Scholar
- 10.Sainsous J, Serradimigni A, Richard JL, Guize L, Leconte T, Tanielian P (1985) How many patients with acute myocardial infarction could be treated in France by intravenous streptokinase? Results of a prospective trial (ENIM 1984). Eur Heart J Suppl 1, 67; (abstract) 197.Google Scholar
- 12.EMIP subcommittee (1987) Potential time saving with pre-hospital intervention in acute myocardial infarction (submitted).Google Scholar
- 14.Villemant D, Barriot P, Bodenan P (1987) Thrombolysis in acute myocardial infarction. A race against time. In: JL Vincent (ed) Update in Intensive Care and Emergency Medicine, vol 3. Springer, Berlin Heidelberg New York London Paris Tokyo, pp 277–286.Google Scholar
- 16.Editorial (1987) Thrombolytic therapy for acute myocardial infarction. Lancet ii:138-140.Google Scholar
- 17.Bippus PH, Haux R, Schroder R (1987) Prehospital intravenous streptokinase in evolving myocardial infarction: a randomized study about feasibility, safety and time gain. Eur Heart Journal 8, 103.Google Scholar